FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

395943007: Felypressin (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1469883013 Felypressin (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1489575019 Felypressin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
811001000172116 félypressine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Felypressin (substance) Is a vasoconstricteur false Inferred relationship Some
Felypressin (substance) Is a Substance with vasopressin receptor agonist mechanism of action (substance) true Inferred relationship Some
Felypressin (substance) Is a Vasopressor true Inferred relationship Some
Felypressin (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Vasopressin receptor agonist (disposition) true Inferred relationship Some
Felypressin (substance) Is a Cyclic peptide (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing felypressin and prilocaine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Felypressin (substance) Inferred relationship Some 2
Prilocaine hydrochloride+felypressin 3%/0.03units dental cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Felypressin (substance) Inferred relationship Some
Prilocaine hydrochloride+felypressin 3%/0.06units/2mL self aspirating cartridge The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Felypressin (substance) Inferred relationship Some
Product containing precisely felypressin 0.06 unit/2 milliliter and prilocaine hydrochloride 60 milligram/2 milliliter conventional release solution for injection cartridge The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Felypressin (substance) Inferred relationship Some 2
Product containing precisely felypressin 0.06 unit/2 milliliter and prilocaine hydrochloride 60 milligram/2 milliliter conventional release solution for injection cartridge This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Felypressin (substance) Inferred relationship Some 2
Product containing felypressin and prilocaine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Felypressin (substance) Inferred relationship Some 2
Felypressin and prilocaine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Felypressin (substance) Inferred relationship Some 2
Felypressin and prilocaine only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Felypressin (substance) Inferred relationship Some 2
Product containing precisely felypressin 0.03 unit/1 milliliter and prilocaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Felypressin (substance) Inferred relationship Some 2
Product containing precisely felypressin 0.03 unit/1 milliliter and prilocaine hydrochloride 30 milligram/1 milliliter conventional release solution for injection (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Felypressin (substance) Inferred relationship Some 2

This concept is not in any reference sets

Back to Start